Thirty-eight patients with hematological malignancy underwent allogenic bone marrow transplantation on 39 occasions between Aug 1984 and Feb 1995. For thirty-eight patients (97.4%), engraftment was carried out. Five years disease free survival (DFS) of all patient (18 with acute lymphoblastic leukemia